Akoya Biosciences, Inc. - Common Stock, $0.00001 par value per share (AKYA)

75 filings reported holding AKYA - Akoya Biosciences, Inc. - Common Stock, $0.00001 par value per share as of Q2 2024.
Akoya Biosciences, Inc. - Common Stock, $0.00001 par value per share (AKYA) has 58 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 12,385,236 shares of 54,965,124 outstanding shares and own 23% of the company stock.
Largest 10 shareholders include Blue Water Life Science Advisors, LP (4,697,785 shares), BlackRock Inc. (1,501,887 shares), VANGUARD GROUP INC (1,463,853 shares), GEODE CAPITAL MANAGEMENT, LLC (562,123 shares), SVB WEALTH LLC (515,317 shares), STATE STREET CORP (434,935 shares), Parkman Healthcare Partners LLC (375,536 shares), PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE (350,000 shares), Polar Capital Holdings Plc (329,756 shares), and Schonfeld Strategic Advisors LLC (294,342 shares).
This table shows the top 58 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.